James Hellinger
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS Research and Interventions 19
- HIV/AIDS drug development and treatment 14
- Virology 12
- HIV Research and Treatment 12
- Co-authors
- Kelly A. Gebo (10 shared papers)John A. Fleishman (9 shared papers)P. Todd Korthuis (7 shared papers)Richard D. Moore (5 shared papers)Philip Keiser (4 shared papers)Richard Conviser (3 shared papers)Paul Gaist (5 shared papers)Fred J. Hellinger (2 shared papers)
- Journals
- HIV Clinical Trials (3 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)AIDS Care (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesUnited KingdomVietnam
In The Last Decade
James Hellinger
28 papers receiving 1.7k citations
James Hellinger's Hit Papers
Peers
Comparison fields: 5 of 107
- Virology 819
- Infectious Diseases 1.4k
- Emergency Medicine 329
- Epidemiology 741
- Applied Microbiology and Biotechnology 38
Countries citing papers authored by James Hellinger
This map shows the geographic impact of James Hellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Hellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Hellinger more than expected).
Fields of papers citing papers by James Hellinger
This network shows the impact of papers produced by James Hellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Hellinger. The network helps show where James Hellinger may publish in the future.
Co-authors
The 25 scholars most cited alongside James Hellinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1 Hit paper breakdown → | 1994 | 432 |
| 2 | 2004 | 240 | |
| 3 | 2010 | 153 | |
| 4 | 2005 | 142 | |
| 5 | 2010 | 141 | |
| 6 | 2008 | 91 | |
| 7 | 2007 | 71 | |
| 8 | 2008 | 70 | |
| 9 | 2012 | 68 | |
| 10 | 2015 | 54 | |
| 11 | 2010 | 52 | |
| 12 | 2009 | 49 | |
| 13 | 2008 | 34 | |
| 14 | 2009 | 33 | |
| 15 | 2007 | 24 | |
| 16 | 1996 | 24 | |
| 17 | 2013 | 23 | |
| 18 | 2003 | 21 | |
| 19 | 2000 | 18 | |
| 20 | 2008 | 17 |
About James Hellinger
James Hellinger is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Molecular Biology, having authored 30 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (19 papers), HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (12 papers), HIV-related health complications and treatments (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), HIV, Drug Use, Sexual Risk (6 papers), Pharmacological Effects and Toxicity Studies (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Virology (819 citations), Infectious Diseases (1.4k citations), Emergency Medicine (329 citations), Epidemiology (741 citations) and Applied Microbiology and Biotechnology (38 citations). James Hellinger has collaborated with scholars based in United States, United Kingdom and Vietnam. Frequent co-authors include Kelly A. Gebo, John A. Fleishman, P. Todd Korthuis, Richard D. Moore, Philip Keiser, Richard Conviser, Paul Gaist, Fred J. Hellinger, William C. Mathews and Joshua Josephs. Their work appears in journals such as HIV Clinical Trials, JAIDS Journal of Acquired Immune Deficiency Syndromes, Antimicrobial Agents and Chemotherapy, AIDS Care and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.